Aluminum contamination in products used in parenteral nutrition: Has anything changed?

Nutrition

Volumn 26, Issue 6, 2010, Pages 585-594

  Gura, Kathleen M ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Aluminum; Aluminum toxicity; Calcium gluconate; Metabolic bone disease; Organic phosphate salts; Parenteral nutrition

Indexed keywords

ALUMINUM; CALCIUM; CALCIUM CHLORIDE; DEFEROXAMINE; ERYTHROPOIETIN; GLUCONATE CALCIUM;

ALUMINUM BLOOD LEVEL; ALUMINUM OVERLOAD; CLINICAL FEATURE; CONTINUOUS INFUSION; DIETARY INTAKE; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL ABSORPTION; HIGH RISK PATIENT; HUMAN; HYPOCALCEMIA; IRON DEFICIENCY ANEMIA; MEDICAL LITERATURE; METABOLIC BONE DISEASE; NEUROTOXICITY; NUTRITIONAL ASSESSMENT; OSTEOPOROSIS; PARENTERAL NUTRITION; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SYMPTOMATOLOGY; ELEMENTAL DIET; ENVIRONMENTAL EXPOSURE; FOOD CONTAMINATION; LEGISLATION AND JURISPRUDENCE; MAXIMUM ALLOWABLE CONCENTRATION; PRACTICE GUIDELINE; PREVENTION AND CONTROL; TOXICITY; UNITED STATES;

ALUMINUM; ENVIRONMENTAL EXPOSURE; FOOD CONTAMINATION; FOOD, FORMULATED; HUMANS; MAXIMUM ALLOWABLE CONCENTRATION; PARENTERAL NUTRITION; PRACTICE GUIDELINES AS TOPIC; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 77952745878     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2009.10.015     Document Type: Review

References (85)

1. Larchet M., Chaumont P., Galliot M., Bourdon R., Goulet O., Ricour C. Aluminum loading in children receiving long-term parenteral nutrition. Clin Nutr 1990, 9:79-83.
2. Aluminum in large and small volume parenterals used in total parenteral nutrition. Fed Regist 2000, 65:4103-4111. Food and Drug Administration.
3. Young D. FDA aluminum rule poses challenges for industry, pharmacists. Am J Health Syst Pharm 2004, 61(8):742-744.
4. Greger J., Sutherland J. Aluminum exposure and metabolism. Crit Rev Clin Lab Sci 1997, 34:439-474.
5. Advenier E., Landry C., Colomb V., Cognon C., Pradeau D., Florent M., et al. Aluminum contamination of parenteral nutrition and aluminum loading in children on long-term parenteral nutrition. J Pediatr Gastroenterol Nutr 2003, 36(4):448-453.
6. Ward M.K., Feest T.G., Ellis H.A. Osteomalacic dialysis osteodystrophy: evidence for a water-borne aetiological agent, probably aluminium. Lancet 1978, 1(8069):841-845.
7. Edwardson J.A., Moore P.B., Ferrier I.N. Effect of silicon on gastrointestinal absorption of aluminium. Lancet 1993, 342:211-212.
8. Sedman A.B., Klein G.L., Merritt R.J., Miller N.L., Weber K.O., Gill W.L., et al. Evidence of aluminum loading in infants receiving intravenous therapy. N Engl J Med 1985, 312(21):1337-1343.
9. Zenz C. Occupational medicine 1994, Mosby-Year Book, Inc, St. Louis, MO. 3rd ed.
10. Yokel R.A., McNamara P.J. Aluminum toxicokinetics: an updated minireview. Pharmacol Toxicol 2001, 88:159-167.
11. Priest N.D., Talbot R.J., Newton D., Day J.P., King S.J., Fifield L.K. Uptake by man of aluminium in a public water supply. Hum Exp Toxicol 1998, 17(6):296-301.
12. Klein G.L. Aluminum in parenteral solutions revisited-Again. Am J Clin Nutr 1995, 61:449-456.
13. Alfrey A.C., Hegg A., Creswell P. Metabolism and toxicity of aluminum in renal failure. Am J Clin Nutr 1980, 33:1509-1516.
14. Alfrey A.C. Aluminum metabolism. Kidney Int 1986, 29(suppl 18):8S-11S.
15. Wilhelm M., Jager D.E., Ohnesorge F.K. Aluminum toxicokinetics. Pharmacol Toxicol 1990, 66:4-9.
16. Harris W.R., Berthon G., Day J.P. Speciation of aluminum in biological systems. J Toxicol Environ Health 1996, 48:543-568.
17. Priest N.D., Newton D., Day J.P. Human metabolism of aluminium-26 and gallium-67 injected as citrates. Human Exp Toxicol 1995, 14:287-293.
18. Klein G.L., Alfrey A.C., Miller N.L., Sherrard D.J., Hazlet T.K., Ament M.E., et al. Aluminum loading during total parenteral nutrition. Am J Clin Nutr 1982, 35(6):1425-1429.
19. Sorenson J.R.J., Campbell I.R., Tepper L.B. Aluminum in the environment and human health. Environ Health Perspect 1974, 8:3-95.
20. Gregor J.L., Sutherland J.E. Aluminum exposure and metabolism. Crit Rev Clin Lab Sci 1997, 34:439-474.
21. Aslam D.K., Pejovic-Millic A., Chettle D.R. In vivo measurement of bone aluminum in population living in southern Ontario, Canada. Physics 2008, 35:5115-5123.
22. D'Haese P.C., Couttenye M.M., Goodman W.G. Use of the low-dose desferrioxamine test to diagnose and differentiate between patients with aluminium-related bone disease, increased risk for aluminium toxicity, or aluminium overload. Nephrol Dial Transpl 1995, 10:1874-1884.
23. Hernandez C.J., Beaupré G.S., Carter D.R. A theoretical analysis of the relative influences of peak BMD, age-related bone loss and menopause on the development of osteoporosis. Osteoporos Int 2003, 14(10):843-847.
24. Klein G.L., Snodgrass W.R., Griffin M.P. Hypocalcemia complicating deferoxamine therapy in an infant with parenteral nutrition-associated aluminum overload: Evidence for a role of aluminum in the bone disease of infants. J Ped Gastroenterol Nutr 1989, 9:400-403.
25. Elliott H.I., Macdougall A.I., Hause G., Cumming R.L., Gardiner P.H., Fell G.S. Plasmapheresis in the treatment of dialysis encephalopathy. Lancet 1978, 2:940-941.
26. Klein G.L., Targoff C.M., Ament M.E., Sherrard D.J., Bluestone R., Young J.H., et al. Bone disease associated with total parenteral nutrition. Lancet 1980, 2(8203):1041-1044.
27. Acca M., Ragno A., Francucci C.M., D'Erasmo E. Metabolic bone diseases during long-term total parenteral nutrition. J Endocrinol Invest 2007, 30:54-59.
28. Leung F.Y., Grace D.M., Alfieri M.A., Bradley C. Abnormal trace elements in a patient on total parenteral nutrition with normal renal function. Clin Biochem 1995, 28(3):297-302.
29. Parenteral drug products containing aluminum as an ingredient or a contaminant: response to Food and Drug Administration notice of intent and request for information. J Parenter Enteral Nutr 1991, 15:194-198. ASCN/ASPEN Working Group on Standards for Aluminum Content of Parenteral Nutrition Solutions.
30. Golub M.S., Domingo J.L. Fetal aluminum accumulation. Teratology 1998, 58(6):225-226.
31. Moreno A., Dominguez C., Ballabriga A. Aluminum in the neonate related to parenteral nutrition. Acta Pediatr 1994, 83:25-29.
32. Heyman M., Klein G., Wong A., Recker R.R., Tyrrell J.B., Alfrey A.C. Aluminum does not accumulate in teenagers and adults on prolonged parenteral nutrition containing free form amino acids. J Parenter Enteral Nutr 1986, 10:86-87.
33. Stauber J.L., Florence T.M., Davies C.M., Adams S.M., Buchanan S.J. Bioavailability of Al in alum-treated drinking water. J AWA 1999, 91:84-93.
34. Gilbert-Barness E., Barness L.A., Wolff J. Aluminum toxicity. Arch Pediatr Adolesc Med 1998, 152(5):511-512.
35. Koo W.W., Kaplan L.A. Aluminum and bone disorders: with specific reference to aluminum contamination of infant nutrients. J Am Coll Nutr 1988, 7(3):199-214.
36. Koo W.W., Kaplan L.A., Krug-Wispe S.K. Aluminum contamination of infant formulas. J Parenter Enteral Nutr 1988, 12(2):170-173.
37. Recknagel S., Bratter P., Chrisafidou A., Gramm H.J., Kotwas J., Rösick U. Parenteral aluminum loading in critical care medicine part I: aluminum content of infusion solutions and solutions for parenteral nutrition. Infusions Ther Transf Med 1994, 21:266-273.
38. Shike M., Shils M., Heller A., Alcock N., Vigorita V., Brockman R., et al. Bone disease in prolonged parenteral nutrition: osteopenia without mineralization defect. Am J Clin Nutr 1986, 44:89-98.
39. Jeffery E.H., Abreo K., Burgess E. Systemic aluminum toxicity: effects on bone, hematopoietic tissue, and kidney. J Toxicol Environ Health 1996, 48:649-665.
40. Fiejka M., Fiejka E., Dougaszek M. Effect of aluminum hydroxide administration on normal mice: tissue distribution and ultrastructure localization of aluminum in liver. Pharma Toxicol 1996, 78:123-128.
41. Smans K.A., D'Haese P.C., Van Landeghem G.F., Andries L.J., Lamberts L.V., Hendy G.N., et al. Transferrin-mediated uptake of aluminium by human parathyroid cells results in reduced parathyroid hormone secretion. Nephrol Dial Transplant 2000, 15(9):1328-1336.
42. Pironi L., Zolezzi C., Ruggeri E., Paganelli F., Pizzoferrato A., Miglioli M. Bone turnover in short-term and long-term home parenteral nutrition for benign disease. Nutrition 2000, 16(4):272-277.
43. Naylor K.E., Eastell R., Shattuck K.E., Alfrey A.C., Klein G.L. Bone turnover in preterm infants. Pediatr Res 1999, 45(3):363-366.
44. Fewtrell M.S., Bishop N.J., Edmonds C.J., Isaacs E.B., Lucas A. Aluminum exposure from parenteral nutrition in preterm infants: bone health at 15-year follow-up. Pediatrics 2009, 124(5):1372-1379.
45. Van Landeghem G.F., D'Haese P.C., Lamberts L.V., De Broe M.E. Competition of iron and aluminum for transferrin: the molecular basis for aluminum deposition in iron-overloaded dialysis patients?. Exp Nephrol 1997, 5(3):239-245.
46. Drueke T.B., Lacour B., Touam M. Effect of aluminum on hematopoiesis. Kidney Int Suppl 1986, 18:45S-48S.
47. Lukiw W.J. Alzheimer's disease and aluminum. Mineral and metal neurotoxicology 1997, 112-126. CRC Press, Boca Raton, FL. M. Ysui, M.J. Strong, K. Ota, V.M. Anthony (Eds.).
48. Spofforth J. A case of aluminum poisoning. Lancet 1921, 197:1301.
49. Alfrey A.C., LeGendre G.R., Kachney M.D. The dialysis encephalopathy syndrome: possible aluminum intoxication. N Engl J Med 1976, 294:184-188.
50. McLachlan D.R.C. Aluminium and the risk for Alzheimer's disease. Environmetrics 1995, 6:233-275.
51. Bishop N.J., Morley R., Day J.P., Lucas A. Aluminum neurotoxicity in preterm infants receiving intravenous-feeding solutions. N Engl J Med 1997, 336(22):1557-1561.
52. Lu Z.Y., Gong H., Amemiya T. Aluminum chloride induces retinal changes in the rat. Toxicol Sci 2002, 66(2):253-260.
53. Hamilton C., Seidner D. Metabolic bone disease and parenteral nutrition. Curr Gastroenterol Rep 2004, 6:335-341.
54. Popinska K., Kierkus J., Lyszkowska M., Socha J., Pietraszek E., Kmiotek W., et al. Aluminum contamination of parenteral nutrition additives, amino acids solutions, and lipid emulsions. Nutrition 1999, 15:683-686.
55. Klein G.L., Campbell G.A., Hodsman A.B., Alfey A.C. Histochemical detection of aluminum in bone but not in brain of infants on parenteral nutrition. Pediatr Res 1991, 29:105A. [abstract].
56. Klein G.L., Naylor K.E., Eastell R., Alfrey A.C., Russell R.G.G. Biochemical markers of bone turnover in premature infants: relation to serum calcium and aluminum intake. Clin Res 1993, 41:755A. [abstract].
57. Speerhas R.A., Seidner D.L. Measured versus estimated aluminum content of parenteral nutrient solutions. Am J Health Syst Pharm 2007, 64(7):740-746.
58. Poole R.L., Hintz S.R., Mackenzie N.I., Kerner J.A. Aluminum exposure from pediatric parenteral nutrition: meeting the new FDA regulation. J Parenter Enteral Nutr 2008, 32(3):242-246.
59. Brown R.O., Morgan L.M., Bhattacharya S.K., Johnson P.L., Minard G., Dickerson R.N. Potential aluminum exposure from parenteral nutrition in patients with acute kidney injury. Ann Pharmacother 2008, 42(10):1410-1415.
60. Canada T.W. Aluminum exposure through parenteral nutrition formulations: Mathematical versus clinical relevance. Am J Health Syst Pharm 2005, 62(3):315-318.
61. Koo W.W., Kaplan L.A., Bendon R., Succop P., Tsang R.C., Horn J., et al. Response to aluminum in parenteral nutrition during infancy. J Pediatr 1986, 109(5):877-883.
62. Driscoll M., Driscoll D.F. Calculating aluminum content in total parenteral nutrition admixtures. Am J Health Syst Pharm 2005, 62(3):312-315.
63. Wilhelm M., Hoelzer J., Luebbers K., Stoehr G., Ohmann C. Aluminum balance in intensive care patients. J Trace Elem Med Biol 2001, 14(4):223-227.
64. Klein G.L., Herndon D.N., Rutan T.C., Barnett J.R., Miller N.L., Alfrey A.C. Risk of aluminum accumulation in patients with burns and ways to reduce it. J Burn Care Rehabil 1994, 15(4):354-358.
65. Koo W.W.K., Kaplan L.A., Horn J., Tsang R.C., Steichen J.J. Aluminum in parenteral solutions-sources and possible alternatives. J Parenter Enteral Nutr 1986, 10:591-595.
66. Food and Drug Administration. Parenteral drug products containing aluminum as an ingredient or a contaminant: notice of intent and request for information. Fed Regist 1990, 55:20799-20802. Department of Health and Human Services.
67. Allwood M.C. Aluminium in parenteral nutrition admixtures: an unnecessary risk?. Nutrition 1999, 15(11-12):958-959.
68. Savory J., Golub H., Yokel R. Aluminum toxicity: issues and insight. Talecris Biotherapeutics 2005.
69. Bohrer D., do Nascimento P.C., Binotto R., Becker E., Pomblum S. Contribution of the raw material to the aluminum contamination in parenterals. J Parenter Enteral Nutr 2002, 26(6):382-388.
70. Holberg C.P. Aluminum in parenteral products: overview of chemistry concerns and regulatory actions. J Parenter Sci Technol 1989, 43:127-131.
71. Inoue M., Gion Y., Itoh H., Ikariya K., Takechi K., Morimoto K., et al. Reduction of aluminium concentration in albumin products. Vox Sang 1994, 66(4):249-252.
72. Frey O.R., Maier L. Polyethylene vials of calcium gluconate reduce aluminum contamination of TPN. Ann Pharmacother 2000, 34(6):811-812.
73. Bohrer D., do Nascimento P.C., Binotto R., Becker E. Influence of the glass packing on the contamination of pharmaceutical products by aluminium. Part III: interaction container-chemicals during the heating for sterilisation. J Trace Elem Med Biol 2003, 17(2):107-115.
74. Bohrer D., Bortoluzzi F., Cícero do Nascimento P., de Carvalho L.M., de Oliveira S.R. Low availability of aluminum in formulations for parenteral nutrition containing silicate. J Parenter Enteral Nutr 2009, Epub ahead of print.
75. Bohrer D., Bertagnolli D.C., de Oliveira S.M., do Nascimento P.C., de Carvalho L.M., Garcia S.C., et al. Role of medication in the level of aluminium in the blood of chronic haemodialysis patients. Nephrol Dial Transplant 2009, 24(4):1277-1281.
76. Lester L.R., Crill C.M., Hak E.B. Should adding albumin to parenteral nutrient solutions be considered an unsafe practice?. Am J Health Syst Pharm 2006, 63(17):1656-1661.
77. Allwood M.C. Aluminium in parenteral nutrition admixtures: an unnecessary risk?. Nutrition 1999, 15(11-12):958-959.
78. Smith B.S., Kothari H., Hayes B.D., Tataronis G., Hudlin M., Doole J., et al. Effect of additive selection on calculated aluminum content of parenteral nutrient solutions. Am J Health Syst Pharm 2007, 64(7):730-739.
79. Klein G., Berquist W., Ament M., Coburn J.W., Miller N.L., Alfrey A.C. Hepatic aluminum accumulation in children on total parenteral nutrition. J Pediatr Gastroenterol Nutr 1984, 3:740-743.
80. Devlieger H., Meyers Y., Willems L., de Zegher F., Van Lierde S, Proesmans W., et al. Calcium and phosphorus retention in the preterm infant during total parenteral nutrition. A comparative randomised study between organic and inorganic phosphate as a source of phosphorus. Clin Nutr 1993, 12(5):277-281.
81. Kerr D.N., Ward M.K., Arze R.S. Aluminum-induced dialysis osteodystrophy: the demise of " Newcastle bone disease" ?. Kidney Int 1986, 29(suppl 18):58S-64S.
82. Vargas J.H., Klein G.L., Ament M.E., Ott S.M., Sherrard D.J., Horst R.L., et al. Metabolic bone disease of total parenteral nutrition: course after changing from casein to amino acids in parenteral solutions with reduced aluminum content. Am J Clin Nutr 1988, 48:1070-1078.
83. Draper H.H., Yuen D.E., Whyte R.K. Calcium glycerophosphate as a source of calcium and phosphorus in total parenteral nutrition solutions. J Parenter Enteral Nutr 1991, 15(2):176-180.
84. Ronchera-oms C.L., Allwood M.C., Hardy G. Organic phosphates in parenteral nutrition: pouring fresh water into an old bucket. Nutrition 1996, 12(5):388-389.
85. Low-aluminum calcium salts. Pharmaceut Technol 2005, 29:194. Advanstar Communications, Inc.